Amerikanische Gesellschaft für Hirudotherapie

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea

Research article published in Zootaxa (2024)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)ArzneimittelentwicklungSawyer RT et al. · Zootaxa, 2024

Abstract

This is a twelve-year longitudinal study of a common snail-feeding leech indigenous to the Albemarle region of northeastern North Carolina, USA. Based on contents of this paper the species is provisionally identified as Helobdella lineata (Verrill, 1874). For all practical purposes this is the first comprehensive description of this species. Particular attention is focused on variability of its dorsal papillae and variable pigment patterns within the Albemarle population. A total of 404 specimens were collected from 25 collecting stations in disparate parts of the region. Specialised leech traps set in these swamps were monitored regularly yielding unprecedented information on its morphology, ecology and general biology. This study recognises four principal pigment variants within the Albemarle region which, based on dissections, appear to represent a single biological species. Moreover, limited observations suggest that pigment variability is attributable primarily to adaptive camouflage to local surroundings. Methodologically it is emphasized in this paper that variable traits cannot serve as key taxonomic anchors. A proposed alternative diagnosis for identifying H. lineata is based entirely on more rigorous, non-variable characters. A significant finding is that H. lineata is most meaningfully understood in terms of specialist adaptation to feeding on snails. Furthermore, it is proposed that such adaptation required a major evolutionary shift within the foregut of this species. Evidence is presented that H. lineata uses uniquely large salivary cells to dissolves solid snail tissue into a semi-fluid state before ingestion via a specialised proboscis. This is the first example of extra-oral digestion in the Hirudinea.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsLeechesNorth CarolinaSnailsFemaleAnimal StructuresAnimal DistributionFeeding BehaviorMaleBody SizeEcosystemOrgan Size

Zusammenfassung

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea.

Warum dies für die Hirudotherapie relevant ist

This twelve-year longitudinal study examined the biology, morphology, and taxonomy of a snail-feeding leech in North Carolina, provisionally identified as Helobdella lineata. The researchers provided a comprehensive species description and presented the first evidence of extra-oral digestion in Hirudinea, noting that the leech uses uniquely large salivary cells to dissolve solid snail tissue into a semi-fluid state before ingestion. While this highlights the digestive biochemical potential of leech salivary secretions, its relevance to ASH is highly indirect. The study is purely taxonomic and ecological, focusing on a non-hematophagous leech species, and provides no applicable insights into human hirudotherapy or the medical properties of blood-feeding leech saliva.

Zitation

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea

Sawyer RT et al. · Zootaxa, 2024

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.